Table 4 Pre- and intraoperative mean radiation exposure of the clinical staff by SLNB in different tumour entities
Tumour entity | ||||||
|---|---|---|---|---|---|---|
Penile carcinoma | Malignant melanoma | Breast cancer | ||||
applied activity [MBq] Tc-99 m-labelled nanocolloid | 150 2-day protocol | 45 1-day protocol | 150 2-day protocol | |||
mean Effective Dose E [μSv] | mean Organ-dose of the hands Hhands [μSv] | mean Effective Dose E [μSv] | mean Organ-dose of the hands Hhands [μSv] | mean Effective Dose E [μSv] | mean Organ-dose of the hands Hhands [μSv] | |
clinical staff | ||||||
nuclear medicine physician | 105 | 20 | 2 | 10 | 0.6 | 10 |
nuclear medicine technologist | 0.5 | 10 | 0.5 | 10 | 0.2 | 10 |
surgeon | 4.0 | 100 | 0.5 | 7 | 0.6 | 5 |
anesthetist | 1.0 | - | 0.7 | - | 0.4 | - |
surgical staff | 1.0 | - | 0.5 | - | 0.4 | - |